Most lately, it has been determined that conolidine and the above mentioned derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent locations as classical opioid receptors, it binds to some big selection of endogenous opioids. Compared with most opioid receptors, this receptor acts like a scavenger and will not activate